Cardiac transplantation beyond 55 years of age.
Between January 1985 and December 1988, 20 patients over the age of 55 years (extremes 56-63 years; 15 men and 5 women) underwent cardiac transplantation. The cause of cardiopathy was ischemic in 70% of the cases. The immunosuppressive regimen consisted of cyclosporin A, corticoids, and azathioprine. Rejection episodes were monitored by endomyocardial biopsies and treated by pulses of corticoids or monoclonal antibodies (OKT3). The operative mortality was 10% (n = 2). The 1-year survival rate was 70%. The 1-year incidence of infection and/or rejection episodes was 1 and 1.53 episodes/patient, respectively. One patient was successfully retransplanted after 9 months because of intractable rejection. Age beyond 55 years is no longer a contraindication to cardiac transplantation. This change in recipient selection policy should lead to parallel changes in donor selection criteria.
Defraigne
J O
JO
Department of Surgery, C.H.U. Liège, Sart-Tilman, Belgium.
Demoulin
J C
JC
Beaujean
M A
MA
Delbouille
M H
MH
Meurisse
M
M
Limet
R
R
D000367:Age Factors; D000075202:Contraindications; D003327:Coronary Disease / Q000601:surgery; D005260:Female; D006084:Graft Rejection; D016027:Heart Transplantation / Q000009:adverse effects / Q000401:mortality; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D012086:Reoperation
D007166:Immunosuppressive Agents